市場調查報告書
商品編碼
1541702
2024-2032 年按產品(儀器、耗材、配件)、應用(臨床研究、診斷、法醫等)和地區分類的高效液相層析 (HPLC) 市場報告High-Performance Liquid Chromatography (HPLC) Market Report by Product (Instruments, Consumables, Accessories), Application (Clinical Research, Diagnostics, Forensic, and Others), and Region 2024-2032 |
2023 年,全球高效能液相層析 (HPLC) 市場規模達到 56 億美元。 展望未來, IMARC Group預計到 2032 年,市場規模將達到 82 億美元,2024 年複合年成長率 (CAGR) 為 4.1%。 .
高效液相層析(HPLC)是指從混合物中分離不同化合物的層析技術。該技術使用玻璃儲液器來容納溶液,使用多個泵來輸送含有樣品混合物的加壓液體溶劑,使用固體吸附材料填充的色譜柱、螢光、質譜、紫外線 (UV) 光譜和電化學檢測器和資料收集系統。它通常用於分析化學和生物化學,以識別、量化和純化各個成分。因此,該技術廣泛應用於微量分析、疾病臨床診斷、食品品質控制和藥物開發。
全球製藥業的顯著成長是創造積極市場前景的關鍵因素之一。 HPLC 廣泛用於分析藥物樣品、品質控制、製造複雜的藥物並獲得更快、更準確的化合物分離結果。此外,對用於純化單株抗體的可靠 HPLC 系統的需求不斷成長也推動了市場的成長。柱和泵浦技術的各種進步以及小型化、自動化和電腦化 HPLC 設備的開發是其他成長誘導因素。這些進步有助於進行高品質的分析,在更短的時間內提供更準確的結果,並增強使用者的整體便利性。 HPLC 儀器製造商也正在開發創新的色譜柱設計,能夠承受較小的表面多孔顆粒的高壓,這是另一個主要的生長誘導因素。生物樣本庫的新興趨勢以及生命科學領域廣泛的研發(R&D)活動是預計進一步推動市場發展的其他因素。
The global high-performance liquid chromatography (HPLC) market size reached US$ 5.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032.
High-performance liquid chromatography (HPLC) refers to the chromatographic technique of separating different compounds from a mixture. The technique uses a glass reservoir to hold the solution, numerous pumps to pass the pressurized liquid solvent containing the sample mixture, a column filled with a solid adsorbent material, fluorescence, mass-spectrometric, ultraviolet (UV)-spectroscopic and electrochemical detectors and data collection systems. It is commonly used for analytical chemistry and biochemistry to identify, quantify and purify individual components. As a result, the technique finds extensive applications for trace analysis, clinical diagnosis of diseases, quality control in food products and pharmaceutical drug development.
Significant growth in the pharmaceutical industry across the globe represents one of the key factors creating a positive outlook for the market. HPLC is widely used to analyze drug samples, quality control, manufacturing complex pharmaceutical drugs and obtaining faster and accurate compound separation results. Furthermore, the increasing demand for reliable HPLC systems for the purification of monoclonal antibodies is also driving the market growth. Various advancements in the column and pump technologies and the development of miniaturized, automated and computerized HPLC devices are acting as other growth-inducing factors. These advancements have assisted in conducting high-quality analysis that provides more accurate results in lesser time and enhances the overall convenience for the user. HPLC instrument manufacturers are also developing innovative column designs that can withstand high pressure from smaller, superficially porous particles, which is acting as another major growth-inducing factor. The emerging trend of biobanking and extensive research and development (R&D) activities in the field of life sciences are some of the other factors that are anticipated to drive the market further.
IMARC Group provides an analysis of the key trends in each segment of the global high-performance liquid chromatography (HPLC) market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product and application.
Instruments
HPLC System
Automated
Manual
Detectors
Pumps
Others
Consumables
Columns
Tubes
Vials
Filters
Others
Accessories
Clinical Research
Diagnostics
Forensic
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Gilson Inc., Hitachi Ltd., Perkinelmer Inc., Phenomenex Inc. (Danaher Corporation), Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation and Waters Corporation.